MedPath

To compare the efficacy of Itraconazole and Fluconazole in Vulvovaginal candiasis

Phase 4
Conditions
Health Condition 1: N771- Vaginitis, vulvitis and vulvovaginitis in diseases classified elsewhere
Registration Number
CTRI/2019/11/022178
Lead Sponsor
Institute of Venereology Madras Medical College
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

160 married women with vulvovaginal candidiasis attending the venereology OPD during the study period.

Those who are giving consent to participate in the study.

Those who are willing for follow up.

Exclusion Criteria

Pregnant women and women in the puerperal period.

Patients with Chronic or Recurrent Vulvovaginal Candidiasis.

Patients who have received systemic or topical antifungal treatment in the past 1 month.

Patients with concurrent bacterial, viral or trichomonal vaginal infection.

Patients with known allergy to azole drugs.

Patients with coexistent Liver disorders.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath